In a landmark decision, the Drug Enforcement Administration (DEA) has announced its intention to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.
What Rescheduling Means
Moving cannabis to Schedule III would acknowledge its accepted medical use and lower potential for abuse compared to Schedule I substances. This change would have significant implications for research, taxation, and banking.
Impact on the Cannabis Industry
Cannabis businesses could benefit from Section 280E tax relief, potentially saving the industry billions of dollars annually. Banks may also become more willing to provide services to cannabis companies.
Timeline and Next Steps
The rescheduling process requires a public comment period and final rule publication. Industry experts expect the change to take effect within the next 12-18 months.